✦ LIBER ✦

A prospective randomised concurrent comparison of the COBE Spectra version 4.7, COBE Spectra version 6 (auto PBSC™) and Haemonetics MCS+ cell separators for leukapheresis in patients with haematological and non-haematological malignancies

✍ Scribed by Rainer Moog

Book ID: 117788413
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 35 KB
Volume: 25
Category: Article
ISSN: 1473-0502
DOI: 10.1016/s1473-0502(01)00076-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective randomised concurrent compar

Prospective randomised concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (Auto PBSC™), and Haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non haematological malignancies

✍ A.E. Morrison; D. Watson; S. Buchanan; R.H.A. Green 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 2 views

A prospective randomised concurrent comp

A prospective randomised concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (auto PBSC™) and Haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non-haematological malignancies

✍ R.H.A Green; D Watson; S Buchanan; A.E Morrison 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Prospective randomised comparison of the

Prospective randomised comparison of the COBE Spectra version 6 and Haemonetics MCS+ cell separators for hematopoietic progenitor cells leucapheresis in patients with multiple myeloma

✍ A. Abdelkefi; M. Maamar; L. Torjman; S. Ladeb; A. Lakhal; T. Ben Othman; H. Slam 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

A randomised crossover trial of two separators was undertaken to compare the mononuclear cell, CD34+ cell and CFU-GM yield, in patients (<61 years) with previously untreated symptomatic multiple myeloma. After first-line therapy, all patients received mobilising chemotherapy (cyclophosphamide 4 g/m

Prospective, concurrent comparison of th

Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS-3P cell separators for leukapheresis after high-dose filgrastim in patients with hematologic malignancies

✍ Jayesh Mehta; Ray Powles; Jennie Treleaven; Barbara Millar; Helen Proctor; Sandr 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

A prospective study was undertaken to compare the mononuclear cell, CD34+ cell, and CFU-GM yields of the Haemonetics MCS-3P and the Cobe Spectra cell separators in ten patients (nine multiple myeloma and one non-Hodgkin lymphoma) on two consecutive days after mobilization with high-dose filgrastim (